HPS2-THRIVE Trial of ER Niacin/LaropiprantHPS2-THRIVE Trial of ER Niacin/Laropiprant

Will extended release niacin be a help or hindrance to adherence and tolerability factors -- when added to lipid lowering regimens? European Heart Journal

Source: Medscape Today Headlines - May 24, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news